Catalyst

Slingshot members are tracking this event:

Arrowhead Pharma (ARWR) Likely to Announce New Data from Ongoing Phase 2 Studies of ARC-520 in Hepatitis-B in 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ARWR

100%
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2 Data, Arc-520, Hepatitis-b, 2016